TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Carolyn Hawley
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Aardvark Therapeutics granted stock options to four new employees in October and November 2025, with options ranging from 14,766 to 49,849 shares, vesting over four years under their Inducement Equity Incentive Plan.

Insights
MPLX   neutral

Mentioned as a subsidiary owned by Marathon Petroleum, with no specific positive or negative indicators in the article


AARD   positive

Company is actively hiring and incentivizing new employees with stock options, indicating growth and financial stability in their clinical-stage biopharmaceutical development